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Aims: To determine the association between dietary intake and risk of non-severe hypoglycemia in adolescents
with type 1 diabetes.
Methods: Type 1 adolescents from a randomized trial wore a blinded continuous glucose monitoring (CGM)
system at baseline for one week in free-living conditions. Dietary intake was calculated as the average from two
24-h dietary recalls. Non-severe hypoglycemiawas defined as having blood glucose b70 mg/dL for ≥10 min but
not requiring external assistance, categorized as daytime and nocturnal (11 PM–7AM). Data were analyzed
using logistic regression models.
Results: Among 98 participants with 14,277 h of CGM data, 70 had daytime hypoglycemia, 66 had nocturnal
hypoglycemia, 55 had both, and 17 had neither. Soluble fiber and protein intake were positively associated with
both daytime and nocturnal hypoglycemia. Glycemic index, monounsaturated fat, and polyunsaturated fat were
negatively associated with daytime hypoglycemia only. Adjusting for total daily insulin dose per kilogram
eliminated all associations.
Conclusions: Dietary intake was differentially associated with daytime and nocturnal hypoglycemia. Over 80% of
type 1 adolescents had hypoglycemia in a week, which may be attributed to the mismatch between optimal
insulin dose needed for each meal and actually delivered insulin dose without considering quality of
carbohydrate and nutrients beyond carbohydrate.
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r-Davis).1. Introduction
Hypoglycemia occurs frequently in people with type 1 diabetes
with an incidence of over 1–2 episodes per week per patient.1 Youth
with type 1 diabetes are particularly vulnerable to hypoglycemia due
to unpredictable food consumption, erratic physical activity, and
problemswith accurate insulin dosing and detecting hypoglycemia.2,3
Further, their brains are still developing, which put them at risk of
cognitive dysfunction and neurological sequelae of hyperglycemia4
and hypoglycemia.5,6
Hypoglycemia is preventable and nutrition therapy plays a pivotal
role in this.7 Current nutrition guidelines are very specific about how to
treat hypoglycemia when it occurs.2 However, information regarding
whether or how usual dietary intake influences risk of hypoglycemia is
limited, particularly for children with diabetes. Medical nutrition
therapy designed for adults may not be applicable to children, and it
may evenconflictwith theevidence rising frompediatric populations.7,8
Further, the literature has primarily focused on postprandial glycemic
excursions following experimentalmeals in clinical trial settings, which
are directly related to acute dietary effect on blood glucose after
consuming testmeals.8–10 Yet, no studyhas examined the effect of usual
dietary intake on risk of hypoglycemiameasured by continuous glucose
monitor (CGM) in free-living youth with type 1 diabetes, which
associates typical dietary patterns with day-to-day glycemic control.
Non-severe hypoglycemia accounts for 88–98% of all hypoglyce-
mic events in patients with diabetes,11 which is defined as a low blood
glucose event b70 mg/dL but does not require external assistance.5
Complete quantification of non-severe hypoglycemia in an outpatient
setting typically requires CGM. CGM-defined hypoglycemia is recom-
mended by a consensus statement from the American Diabetes
Association as an outcome measure, in addition to HbA1c, for
evaluating glucose control in people with type 1 diabetes.12 In this
study, we aimed to determine the association between usual dietary
intake and risk of developing non-severe hypoglycemia in a sample of
adolescents with type 1 diabetes whowore CGM in a one-week period
at baseline from the Flexible Lifestyle Empowering Change (FL3X)
randomized clinical trial (ClinicalTrials.gov identifier: NCT01286350).
2. Participants and methods
2.1. Participants
The FL3X is an 18-month randomized trial with the primary goal of
improving glycemic control and quality of life in adolescentswith type 1
diabetes through an evidence-based flexible lifestyle intervention. The
intervention focuses on increasing adherence to type 1 diabetes
self-management includingmedical therapy, diet, and physical activity.
Eligible participants were aged 13–16 years at study entry and had
HbA1c 8–13% and duration of diabetes N1 year. Participants were
enrolled from two sites: Barbara Davis Center for Childhood Diabetes in
Colorado and Cincinnati Children's Hospital Medical Center in Ohio,
coordinated by the University of North Carolina (UNC) at Chapel Hill.
Written informed consentwasobtained fromparents or legal guardians.
The current study used baseline data from a subset of 258 adolescents
with type 1 diabetes from the FL3X trial who also participated in the
ancillary study:Measures of Hypoglycemia and Glycemic Variability Using
Continuous Glucose Monitoring. The ancillary study was funded
separately from the FL3X trial. Of all 258 participants, 95 had completed
baseline data collection when the funding was received, and thus were
excluded for the ancillary study. Additional 33 participants were
excluded due to participation refusal (n = 4), not-completed data
collection (n =13), no dietary recall conducted (n = 12), and other
reasons (n = 4). Accordingly, 130 participants who had at least one
completed dietary recall comprised our final study sample. The study
protocol was approved by the Institutional Review Boards at each
participating site. The study was conducted in accordance with the
Declaration of Helsinki. For this investigation, data were collected
during one week period of time at baseline.
2.2. Measuring blood glucose using CGM
At the baseline visit, the iPro2 CGM system (Medtronic Inc.) with
the Enlite sensor was inserted into the abdominal subcutaneous
adipose tissue. Participants were carefully instructed on the use and
maintenance of the CGM system and were advised to calibrate the
sensor before eating and before bed with iPro2 compatible gluc-
ometer (OneTouch Ultra2). The Enlite sensor measured interstitial
glucose level every five min within a range 40–400mg/dL. On the last
day of the CGM wearing week, participants were reminded to sendthe device back, using the pre-paid box/envelope given at the end of
the study visit in the first day. The CGM data were downloaded with
CareLink iPro System and uploaded to the coordinating center for data
processing. CGM readings were blinded to participants. No alarms for
hypoglycemia or hyperglycemia or any communication from the
device were available to participants.
2.3. 24-h dietary and physical activity recalls
Telephone-administered 24-h dietary recalls were administered to
participants (ideally one weekday and one weekend day) to ascertain
dietary intake. Interviews were conducted by trained and certified
interviewers from the UNC NIH/NIDDK Nutrition Obesity Research
Center (NORC) staff (P30DK056350; MPI Mayer-Davis), using the
Nutrient Data System for Research software (NDSR Version 2014,
Nutrition Coordinating Center, University of Minnesota, Minneapolis,
MN) and the multiple pass interviewing method.13,14
The validated Previous Day Physical Activity Recall (PDPAR)15,16
divided the day into half-hour time blocks and queried the dominant
activity and the approximate intensity of that activity for each period.
The intensity level was categorized as light (slow breathing, little or
no movement), moderate (normal breathing and some movement),
hard (increased breathing and moderate movement), and vary hard
(hard breathing and quick movement).The PDPAR was under the
direction of the UNC NORC and administered concurrently with the
24-h dietary recalls.
2.4. Other data
Standardized questionnaires were used to collect self-reported
data including race, highest level of parental education, duration of
diabetes, insulin delivery method, and insulin dose. Weight, height,
and HbA1c level were measured or assayed according to standardized
protocols.
Body mass index (BMI) was computed and converted to a BMI z
score using the Center for Disease Control/National Center for Health
Statistics 2000 reference curves.17
2.5. Statistical analysis
No severe hypoglycemic events were reported during the study
week. Non-severe hypoglycemic events were defined as having CGM
reading b70 mg/dL for 10 min or more.18,19 They were further
categorized into daytime and nocturnal non-severe hypoglycemia.
This distinction is important because current insulin analogues and
subcutaneous delivery methods do not adequately mimic normal
physiologic patterns of insulin secretion20 and sleep attenuates
counter-regulatory responses to hypoglycemia.21 Further, dietary
intake and exercise22 as two major determinants of blood glucose
occur mainly in the daytime. Accordingly, dietary intake is likely to
influence hypoglycemia risk differently during the day and night.
Hypoglycemia that occurred between 11:00 PM and 7:00 AM was
defined as nocturnal hypoglycemia.18,23
Usual daily dietary intake in the study week was averaged from
two 24-h dietary recalls. Macronutrients of interest were total
carbohydrate, total protein, animal protein, plant protein, total fat,
saturated fat (SFA), monounsaturated fat (MUFA), polyunsaturated
fat (PUFA), ratio of MUFA to SFA (MUFA/SFA), and ratio of PUFA to SFA
(PUFA/SFA). Total fiber, soluble fiber (e.g., fiber in oat bran, barley,
seeds, nuts, and lentils), insoluble fiber, glycemic index (GI), and
glycemic load (GL) were also studied.
Patients with no dietary recall, one recall only, and two recalls
were compared. Further, for those with two dietary recalls, patient
characteristics and average daily dietary intake were compared
among four groups of participants: no hypoglycemia, daytime
hypoglycemia only, nocturnal hypoglycemia only, and both daytime
and nocturnal hypoglycemia. Differences were evaluated by the
Wilcoxon–Mann–Whitney test for two-group comparison and
Kruskal–Wallis test for comparison of three or four groups.
Amongthosewith twodietary recalls, logistic regressionmodelswere
used to identify dietary predictors of daytime hypoglycemia (those with
≥1 episode of daytime hypoglycemia versus those without, regardless of
nocturnal hypoglycemia), and nocturnal hypoglycemia (those with ≥1
episode of nocturnal hypoglycemia versus those without, regardless of
daytime hypoglycemia). Odds ratios (ORs) and 95% confidence intervals
(CIs) were estimated. All adjusted models included total calories, CGM
wear time, and average number of meals per day. Other covariates were
also adjusted if associated P value was ≤0.2, including age, gender, race
(white, non-white), highest parental education (four-year college or
more, some college or less), duration of diabetes, BMI z score, hourswith
vigorous or moderate physical activity per day, hours with electronic
media time or TV time per day, and HbA1c level. Finally, insulin delivery
method (pump versus multiple daily injection) and insulin dose per
kilogram were added to the fully adjusted model.
3. Results
3.1. Patient characteristics
Among 258 adolescent participants from the FL3X trial at baseline,
128 had no dietary recall; 32 had only one recall while 98 had twoTable 1





Characteristics, % or mean ± SD
Age, years 14.12 ± 1.22 14.33 ± 1.11
Male 47.06 40.00
White 100.0 93.33
Diabetes duration, years 6.59 ± 3.71 6.29 ± 3.75
HbA1c, % 10.21 ± 1.08 9.61 ± 1.07
HbA1c, mmol/mol 88.05 ± 11.81 81.57 ± 11.70
BMI z score 1.00 ± 1.03 0.47 ± 1.10
On insulin pump 64.71 80.00
Insulin dose per kg, U 1.03 ± 0.37 1.06 ± 0.37
Parental education with 4-year college or more 64.71 60.00
Exercise level
Vigorous, h/day 0.91 ± 1.65 0.72 ± 0.82
Moderate, h/day 2.25 ± 2.00 2.20 ± 1.70
Electronic media time, h/day 2.91 ± 2.14 2.43 ± 1.30
Television, h/day 1.31 ± 1.01 2.12 ± 1.13
Average number of daily meals 4.71 ± 1.23 4.73 ± 1.56
Nutrients, mean ± SD, % of total energy
% calorie from fat 36.87 ± 6.82 34.99 ± 6.27
% calorie from carbohydrate 47.79 ± 8.80 49.20 ± 8.76
% calorie from protein 15.30 ± 4.41 15.85 ± 3.82
% calorie from SFA 12.33 ± 3.61 12.30 ± 3.19
% calorie from MUFA 12.67 ± 2.25 11.71 ± 2.36
% calorie from PUFA 8.91 ± 2.90 7.95 ± 2.51
Nutrients, mean ± SD, g per 1000 kcal
Total carbohydrate 120.66 ± 22.72 123.51 ± 22.01
Total fiber 6.47 ± 1.78 7.98 ± 2.65
Soluble fiber 2.13 ± 0.50 2.77 ± 1.12
Insoluble fiber 4.27 ± 1.41 5.18 ± 1.76
Total protein 37.50 ± 10.10 39.26 ± 8.76
Animal protein 24.81 ± 11.51 26.53 ± 9.06
Plant protein 12.68 ± 3.06 12.72 ± 2.48
Total fat 41.87 ± 7.79 40.09 ± 6.53
SFA 14.00 ± 4.35 14.18 ± 3.68
MUFA 14.37 ± 2.61 13.36 ± 2.56
PUFA 10.16 ± 3.40 9.05 ± 2.84
Glycemic load (glucose reference) 72.24 ± 15.44 68.03 ± 13.37
Glycemic index (glucose reference) 63.48 ± 3.69 59.32 ± 3.61
MUFA/SFA ratio 1.07 ± 0.22 1.00 ± 0.31
PUFA/SFA ratio 0.86 ± 0.43 0.75 ± 0.32
Abbreviation: MUFA, monounsaturated fat; PUFA, polyunsaturated fat; SD, standard deviat
a 10 min or more with low blood glucose b70 mg/dL between 11 PM and 7 AM defined
b P value from Kruskal–Wallis test. P values b0.05 were highlighted in bold.recalls (Supplementary Table 1). The demographics, clinical charac-
teristics, and dietary intake of these three groups were not different.
Among 98 participants who had two 24-h dietary recalls, 17 of
them had no non-severe hypoglycemia during the study week and 55
developed both daytime and nocturnal non-severe hypoglycemia
(Table 1). Participants with non-severe hypoglycemia were not
different from those without in terms of age, gender, race, diabetes
duration, BMI z score, insulin delivery method, insulin dose per
kilogram, parental education, and physical activity. However, lower
HbA1c level was seen in participants with non-severe hypoglycemia.
Regarding dietary intake, descriptively, total fiber including both
soluble fiber and insoluble fiber intake was higher in participants with
non-severe hypoglycemia than those without. Conversely, the GI of
the diet was higher in participants without non-severe hypoglycemia.
Participants with both daytime and nocturnal non-severe hypoglyce-
mia had lower MUFA intake compared to participants with only
daytime or nocturnal non-severe hypoglycemia or without
non-severe hypoglycemia.
3.2. Usual dietary intake and risk of daytime non-severe hypoglycemia
Fully adjusted models show that total carbohydrate and the GL
were not associated with risk of daytime non-severe hypoglycemia
(Fig. 1A, Table 2). Every five units higher in the GI of the diet was
associated with 68% lower risk of daytime non-severe hypoglycemiahypoglycemia during one week at baseline visit.
ia only Nocturnal hypoglycemiaa only
(N = 11)
Daytime and nocturnal hypoglycemiaa
(N = 55)
Pb
14.27 ± 1.01 14.33 ± 1.16 0.90
63.64 52.73 0.67
90.91 87.27 0.53
8.01 ± 5.13 5.83 ± 3.52 0.55
9.84 ± 1.56 9.01 ± 0.94 0.001
84.01 ± 17.01 74.97 ± 10.28 0.001
0.40 ± 0.92 0.62 ± 0.87 0.30
63.64 74.07 0.69
0.98 ± 0.26 0.98 ± 0.28 0.97
63.64 67.27 0.96
1.34 ± 1.06 0.83 ± 0.95 0.24
3.14 ± 1.70 2.60 ± 1.69 0.24
2.80 ± 2.01 2.89 ± 2.37 0.99
1.66 ± 1.11 1.90 ± 1.72 0.36
5.55 ± 1.08 4.81 ± 1.12 0.12
37.46 ± 6.56 34.01 ± 5.50 0.07
48.07 ± 8.64 49.05 ± 5.69 0.51
14.43 ± 3.34 16.93 ± 3.74 0.16
12.49 ± 3.02 12.27 ± 3.02 0.95
13.14 ± 2.57 11.45 ± 2.55 0.04
8.93 ± 2.84 7.25 ± 2.38 0.07
123.00 ± 21.07 124.86 ± 14.81 0.49
8.62 ± 2.62 9.12 ± 3.90 0.01
2.70 ± 0.73 2.99 ± 1.16 0.006
5.89 ± 2.02 6.06 ± 2.97 0.04
36.96 ± 7.77 41.59 ± 9.09 0.17
23.23 ± 8.30 26.71 ± 8.95 0.65
12.73 ± 3.81 14.89 ± 4.52 0.09
42.39 ± 6.72 38.70 ± 6.27 0.09
14.04 ± 3.41 14.01 ± 3.43 0.93
14.96 ± 2.64 12.97 ± 2.85 0.03
10.14 ± 2.92 8.28 ± 2.75 0.06
69.48 ± 11.77 69.33 ± 10.01 0.84
61.33 ± 4.57 60.10 ± 4.27 0.01
1.11 ± 0.27 0.96 ± 0.24 0.08
0.83 ± 0.31 0.69 ± 0.41 0.20
ion; SFA, saturated fat.
nocturnal hypoglycemia.
Fig. 1. Daily macronutrients intake and daytime non-severe hypoglycemia. Legend: SFA, saturated fat; MUFA, monounsaturated fat; PUFA, polyunsaturated fat. Nutrients examined
were: Fig. 1A, carbohydrate; Fig. 1B, fiber; Fig. 1C, protein; Fig. 1D, fat. The models were adjusted for continuous glucose monitor wear time, total energy intake per day, average
number of meals per day, diabetes duration, HbA1c, daily electronic media time in hours, and TV time in hours.(OR, 0.32; 95% CI 0.14–0.73). Intake of soluble fiber, not total fiber,
was positively related to the risk of daytime non-severe hypoglycemia
(Fig. 1B); the OR (95% CI) for every five grams more intake of soluble
fiber with risk of daytime non-severe hypoglycemia was 7.86
(0.98–62.19). Higher total protein intake by 10 g per day was
associated with higher risk of daytime non-severe hypoglycemia (OR,Table 2
Dietary intake and risk of daytime non-severe hypoglycemia.a
Model 1 Model 2 Model
Nutrients Unadjusted Partially adjusted Fully ad
Carbohydrate
Total carbohydrate, per 10 g 0.98 (0.93–1.03) 1.11 (0.95–1.29) 1.03 (0
Total fiber, per 5 g 1.07 (0.74–1.53) 1.48 (0.87–2.53) 1.71 (0
Soluble fiber, per 5 g 1.68 (0.53–5.33) 8.44 (1.34–53.28) 7.86 (0
Insoluble fiber, per 5 g 1.03 (0.62–1.69) 1.37 (0.69–2.71) 1.74 (0
Glycemic index, per 5 U 0.44 (0.24–0.79) 0.40 (0.21–0.76) 0.32 (0
Glycemic load, per 10 U 0.52 (0.22–1.23) 0.69 (0.08–6.19) 0.23 (0
Protein
Total protein, per 10 g 0.99 (0.85–1.16) 1.23 (0.91–1.65) 1.47 (1
Animal protein, per 10 g 0.99 (0.82–1.20) 1.11 (0.84–1.47) 1.27 (0
Plant protein, per 10 g 0.96 (0.61–1.49) 1.65 (0.78–3.49) 1.86 (0
Fat
Total fat, per 5 g 0.94 (0.88–1.00) 0.81 (0.66–0.99) 0.84 (0
SFA, per 5 g 0.93 (0.79–1.09) 1.05 (0.76–1.46) 1.20 (0
MUFA, per 5 g 0.80 (0.67–0.97) 0.54 (0.33–0.88) 0.55 (0
PUFA, per 5 g 0.68 (0.51–0.92) 0.55 (0.34–0.90) 0.47 (0
MUFA/SFA ratio, per 1 U 0.16 (0.03–0.94) 0.17 (0.03–1.04) 0.07 (0
PUFA/SFA ratio, per 1 U 0.41 (0.13–1.26) 0.39 (0.13–1.20) 0.19 (0
Model 1. Unadjusted.
Model 2. Adjusted for continuous glucose monitor wear time, total energy intake per day, a
Model 3. Model 2 + diabetes duration, HbA1c, daily electronic media time in hours, and TV
Model 4. Model 3 + insulin delivery method (pump versus multiple daily injection).
Model 5. Model 4 + insulin dose per kilogram.
Abbreviation. MUFA, monounsaturated fat; PUFA, polyunsaturated fat; SFA, saturated fat.
a Values were odds ratios (95% CIs). Significant results (Pb0.05) were highlighted in bold1.47; 95% CI 1.00–2.17; Fig. 1C). No meaningful difference between
animal and plant protein was found. However, type of fat was
important. Intake of total fat or SFA was not related to risk of daytime
non-severe hypoglycemia while consumption of unsaturated fat was
protective (Fig. 1D). Consuming five g more MUFA (OR, 0.55; 95% CI
0.30–1.00) and PUFA (OR, 0.47; 95% CI 0.24–0.90) per day were3 Model 4 Model 5
justed Adding insulin delivery method Further adding insulin dose/kg
.86–1.22) 1.03 (0.86–1.22) 0.93 (0.75–1.17)
.86–3.40) 1.73 (0.87–3.47) 1.26 (0.54–2.90)
.98–63.19) 8.07 (0.98–66.51) 5.02 (0.29–87.96)
.68–4.47) 1.76 (0.68–4.57) 1.09 (0.36–3.29)
.14–0.73) 0.32 (0.14–0.74) 0.35 (0.12–1.04)
.02–3.49) 0.24 (0.02–3.53) 0.04 (b0.001–2.50)
.00–2.17) 1.47 (1.00–2.17) 1.34 (0.85–2.12)
.91–1.79) 1.28 (0.91–1.80) 1.26 (0.83–1.92)
.78–4.42) 1.87 (0.79–4.47) 1.35 (0.40–4.51)
.67–1.06) 0.84 (0.67–1.06) 1.00 (0.76–1.30)
.80–1.80) 1.20 (0.80–1.81) 1.79 (0.92, 3.48)
.30–1.00) 0.55 (0.30–1.00) 0.93 (0.47–1.83)
.24–0.90) 0.47 (0.24–0.90) 0.55 (0.27–1.11)
.01–0.83) 0.07 (0.006, 0.83) 0.16 (0.008–3.29)
.05–0.78) 0.19 (0.05–0.78) 0.15 (0.03, 0.86)
nd average number of meals per day.
time in hours.
, but p value for total protein in the fully adjusted model (Model 3) was 0.0503.
Table 3
Dietary intake and risk of nocturnal non-severe hypoglycemia.a
Model 1 Model 2 Model 3 Model 4 Model 5
Nutrients Unadjusted Partially adjusted Fully adjusted Adding insulin delivery method Further adding insulin dose/kg
Carbohydrate
Total carbohydrate, per 10 g 0.96 (0.92–1.01) 0.98 (0.86–1.13) 0.95 (0.82–1.11) 0.94 (0.80–1.10) 0.92 (0.76–1.13)
Total fiber, per 5 g 1.11 (0.78–1.58) 1.68 (0.98–2.85) 1.73 (0.97–3.08) 1.58 (0.88–2.86) 1.38 (0.67–2.82)
Soluble fiber. Per 5 g 1.47 (0.49–4.38) 8.43 (1.44–49.46) 8.57 (1.33–55.07) 7.08 (1.08–46.57) 5.06 (0.51–50.40)
Insoluble fiber, per 5 g 1.14 (0.70–1.85) 1.69 (0.85–3.34) 1.76 (0.82–3.75) 1.56 (0.72–3.38) 1.27 (0.51–3.18)
Glycemic index, per 5 U 0.71 (0.42–1.18) 0.79 (0.46–1.36) 0.83 (0.47–1.46) 0.86 (0.48–1.53) 0.57 (0.26–1.24)
Glycemic load, per 10 U 0.45 (0.19–1.03) 0.37 (0.04–3.07) 0.27 (0.03–2.69) 0.27 (0.03–2.93) 0.10 (0.004–2.66)
Protein
Total protein, per 10 g 0.96 (0.82–1.11) 1.24 (0.93–1.66) 1.36 (0.99–1.86) 1.38 (0.99–1.91) 1.35 (0.92–1.98)
Animal protein, per 10 g 0.95 (0.79–1.13) 1.12 (0.86–1.47) 1.21 (0.91–1.60) 1.23 (0.92–1.64) 1.21 (0.86–1.70)
Plant protein, per 10 g 0.93 (0.61–1.43) 1.65 (0.81–3.39) 1.66 (0.77–3.54) 1.56 (0.71–3.45) 1.66 (0.59–4.63)
Fat
Total fat, per 5 g 0.94 (0.88–1.00) 0.96 (0.80–1.14) 0.97 (0.79–1.18) 0.98 (0.79–1.20) 1.00 (0.78–1.28)
SFA, per 5 g 0.91 (0.78–1.07) 1.12 (0.81–1.53) 1.18 (0.84–1.67) 1.17 (0.82–1.67) 1.60 (0.93–2.74)
MUFA, per 5 g 0.85 (0.71–1.02) 0.95 (0.62–1.45) 0.93 (0.57–1.52) 1.00 (0.60–1.68) 1.17 (0.62–2.18)
PUFA, per 5 g 0.72 (0.55–0.95) 0.71 (0.46–1.10) 0.70 (0.44–1.13) 0.71 (0.44–1.16) 0.51 (0.26–1.00)
MUFA/SFA ratio, per 1 U 0.45 (0.09–2.33) 0.41 (0.07–2.33) 0.30 (0.05–1.96) 0.38 (0.06–2.57) 0.18 (0.02–1.89)
PUFA/SFA ratio, per 1 U 0.56 (0.19–1.64) 0.51 (0.17–1.54) 0.42 (0.13–1.39) 0.41 (0.12–1.38) 0.20 (0.04–0.90)
Model 1. Unadjusted.
Model 2. Adjusted for continuous glucose monitor wear time, total energy intake per day, and average number of meals per day.
Model 3. Model 2 + diabetes duration, HbA1c, daily electronic media time in hours, and TV time in hours.
Model 4. Model 3 + insulin delivery method (pump versus multiple daily injection).
Model 5. Model 4 + insulin dose per kilogram.
Abbreviation. MUFA, monounsaturated fat; PUFA, polyunsaturated fat; SFA, saturated fat.
a Values were odds ratios (95% CIs). Significant results (Pb0.05) were highlighted in bold.associated with lower risk of daytime non-severe hypoglycemia. An
inverse association of MUFA/SFA ratio and PUFA/SFA ratio with risk of
daytime non-severe hypoglycemia was also found. Adjusting for
insulin delivery method did not change results. However, after
accounting for insulin dose per kilogram, all associations disappeared
except for PUFA/SFA ratio. Of note, we did not have information on
insulin dose at each meal, so the insulin dose used here was the
self-reported total daily dose at baseline.
3.3. Usual dietary intake and risk of nocturnal non-severe hypoglycemia
Total carbohydrate, the GI, and the GL of the diet were not
associated with risk of nocturnal non-severe hypoglycemia (Table 3,
Fig. 2A), according to results from the fully adjusted model. Similar to
daytime non-severe hypoglycemia, soluble fiber intake per 5 g was
positively associated with risk of nocturnal non-severe hypoglycemia
(OR 8.57, 95% CI 1.33–55.07; Fig. 2B). Higher total protein intake by
10 g was associated with higher risk of nocturnal non-severe
hypoglycemia (OR 1.36, 95% CI 0.99–1.86; Fig. 2C). Dietary fat intake
was not related to risk of nocturnal non-severe hypoglycemia, including
both saturated and unsaturated fat (Fig. 2D). Adjusting for insulin
delivery method did not change results. After accounting for insulin
dose per kilogram, the positive association of soluble fiber and total
protein with risk of nocturnal non-severe hypoglycemia was no longer
statistically significant. Unexpectedly, PUFA/SFA ratio was negatively
associated with risk of nocturnal non-severe hypoglycemia.
4. Discussion
In adolescents with type 1 diabetes, non-severe hypoglycemia was
common. Over 80% of the study participants developed non-severe
hypoglycemia within a week. The mismatch between the insulin dose
delivered and the insulin dose actually needed for each freely-
consumed meal may be responsible. We found that insulin dosing
may need to consider soluble fiber, total protein, MUFA, PUFA, and the
GI, in addition to carbohydrate counting recommended by current
guidelines. Insulin delivery method did not influence dietary
associations with hypoglycemia. Our study suggests that how to
inject correct insulin dose at correct time to match every freelyconsumed meal to reduce clinically unfavorable events such as
hypoglycemia remains challenging in type 1 adolescents.
Our analyses revealed that quality of carbohydrate (i.e., soluble fiber
and glycemic index) needs to be considered for insulin dosing. Previous
literature demonstrated that the reduction of postprandial glucose
responses after carbohydrate-rich meals was mainly driven by soluble
fiber, not insoluble fiber, via hindering macronutrient absorption and
slowing gastric emptying.24 However, none of the published studies in
type 1 diabetes populations in the CGMcontext differentiated two types
of fiber. Nonetheless, Maahs et al.25 reported that every one gram
increase in total dietary fiber intake was associated with 2.4 to 6.5 mg/dL
lowerpostprandial bloodglucoseup to 4 h, in free-living adolescentswith
type1diabetes. Lafranceet al.26 found thathigh-fiberdietdecreasedmean
blood glucose, but did not increase the incidence of hypoglycemia.
However, Lafrance et al. conducted their study inwell-controlled patients
with type 1 diabetes on intensive insulin therapy in a clinical trial setting.
Further, thefiber content in the test breakfast of Lafrance et al.’s studywas
approximately 50 g/1000 kcal, which was substantially higher than that
in our study.
Another important trait of carbohydrate quality is the GI. Existing
evidence indicates that consistent consumption of a low-GI diet may
reduce insulin requirement and improve average blood glucose.27,28 If
usual carbohydrate-to-insulin ratio is used, the risk of hypoglycemia
may be increased with consuming low-GI diet in type 1 diabetes. This
is consistent with our finding that the GI was inversely associated
with risk of daytime non-severe hypoglycemia. However, discerning
the independent effect of the GI from fiber is difficult,7 because foods
rich in fiber generally have a low GI, although not all foods with a low
GI necessarily have a high fiber content.29 Nonetheless, the negative
GI–hypoglycemia relationship remained in our data even after
adjusting for fiber or other major macronutrients (data not shown).
Previous studies consistently reported that low-GI foods or diet
lowered mean blood glucose concentrations and reduced peak
glucose excursion compared to high-GI foods or diet in people with
type 1 diabetes.26,27,30,31 However, the relationship between the GI
and hypoglycemia risk was much less consistent. Nansel et al.27 found
increased incidence of hypoglycemiawith low-GI diet in childrenwith
type 1 diabetes while other studies reported no difference between
low- and high-GI diet regarding hypoglycemia risk.26,31 Notably, these
Fig. 2. Daily macronutrients intake and nocturnal non-severe hypoglycemia. Legend: SFA, saturated fat; MUFA, monounsaturated fat; PUFA, polyunsaturated fat. Nutrients examined
were: Fig. 2A, carbohydrate; Fig. 2B, fiber; Fig. 2C, protein; Fig. 2D, fat. The models were adjusted for continuous glucose monitor wear time, total energy intake per day, average
number of meals per day, diabetes duration, HbA1c, daily electronic media time in hours, and TV time in hours.studies used various definitions of low- and high-GI diet, monitored
different length of blood glucose, and assigned test meals at different
timing. All these may have led to inconsistent findings regarding the
relationship between the GI and hypoglycemia risk.
We found that higher protein intake was associated with higher
risk of non-severe hypoglycemia in adolescents with type 1 diabetes.
In healthy individuals32 or people with type 2 diabetes,33 ingested
protein appears to increase both insulin and glucagon secretion,
usually resulting in no change or lower glucose concentration.
However, the findings in people with type 1 diabetes are different,
because type 1 patients rely exclusively on exogenous insulin. A
review of experimental studies in type 1 diabetes led by Bell et al.28
stated that protein tends to increase glucose concentrations in the late
postprandial period. This conflicts with the positive protein–
hypoglycemia association that we identified in an outpatient setting.
The studies included in the Bell et al.’s review are clinical trials with
predesigned meals and insulin dosing strategy primarily based on
carbohydrate counting. In an outpatient environment, individual
experience commonly leads to adjustments for meals high in fat or
protein, although current guidelines account only for carbohydrate.34
Thus, some study participantsmay bolusmore insulin than needed for
high-protein meals, with or without correct carbohydrate counting,35
resulting in greater hypoglycemia risk. However, this is speculative.
Without mealtime insulin dose matched to each meal, we are unable
to determine when and how the mismatch between dietary intake
and insulin dose occurs. Evidence has also shown that the glycemic
effect of protein depends on carbohydrate content of the meal in type
1 diabetes,28 but we did not find an interaction between carbohydrate
and protein in relation to hypoglycemia risk (data not shown). Of
note, although a bedtime snack containing protein and carbohydrate
is commonly consumed by patients to prevent nocturnal hypoglyce-
mia, currently, there are no clear clinical practice guidelines on the
optimal composition of a bedtime snack.7,36,37Our data also revealed that fat quality mattered in terms of
managing hypoglycemia. To our knowledge, we did not find any diet
and CGM study that distinguished fat types. Rather, dietary fat as a
whole was considered. Studies fromWolpert et al.,38 Smart et al.8 and
other investigators39,40 demonstrated that meals containing carbo-
hydrate and that are also high in dietary fat can cause sustained late
high postprandial blood glucose up to or over 5 h. The relevant
mechanisms are delayed gastric emptying, impaired insulin sensitiv-
ity, and enhanced hepatic glucose production.41 If individuals with
type 1 diabetes do not adjust insulin dose for dietary fat, they may be
more likely to have hyperglycemia instead of hypoglycemia. However,
these findings from previous studies could not explain the difference
between saturated and unsaturated fat. In a randomized trial conducted
among obese adults with type 2 diabetes, a low carbohydrate diet that
was high in unsaturated fat and low in saturated fat reduced glucose
variability measured by 48-h CGM. However, adjusting for glucose
variability did not change our results (data not shown). Also, the
differential effect on insulin resistance between saturated and unsatu-
rated fat does not apply here; unsaturated fat causes less profound
insulin resistance than saturated fat.42
Another notable finding from our study is that dietary intake was a
stronger predictor of non-severe hypoglycemia in the daytime than
nighttime. Similarly, an early large study on type 1 children by Beregszàszi
et al.43 did not find a difference in food consumption in the daytime
betweenparticipantswithnocturnalhypoglycemia and thosewithout. The
GI–hypoglycemia relationship of our study was also consistent with the
Nansel et al.’s study.27 They reported no difference in the mean blood
glucose and hypoglycemia risk in the night between consuming a low-GI
and ahigh-GI diet in type 1 children, although themeanblood glucosewas
lower and hypoglycemia risk was higher in the daytime.27 Probably, the
main reason is that the failure of insulin replacement to mimic normal
insulin secretion of pancreas causes amismatchbetweennighttime insulin
requirements and blood glucose, leading to nocturnal hypoglycemia.20,44
The insulin dose data we used were self-reported usual total
insulin dose at baseline visit. We did not have information on insulin
dose and injection time at each meal. The high hypoglycemia risk in
our participants may be related to both incorrect meal-based insulin
dose and injection time. Optimal amount and delivery patterns of
insulin for meals high in fat or protein or varying in the GI are not yet
fully understood. Also, the insulin injection time depends on blood
glucose concentration, meal composition, exercise, and type of
insulin.45 Therefore, appropriate insulin dosing is complex and
requires substantial behavioral support.
Our study is the largest investigation so far that examined the
association of usual dietary intake with risk of non-severe hypogly-
cemia in adolescents with type 1 diabetes. We used blinded CGM to
document hypoglycemic events, which could more objectively and
completely capture hypoglycemia compared to traditional methods
(e.g., daily blood glucose check and hypoglycemic symptoms).
Nonetheless, misclassification of hypoglycemia may exist due to the
inaccuracy of CGM data. Other limitations should also be noted. First,
we did not have mealtime insulin dose data and did not ask how
participants calculated insulin dose. Therefore, we were unable to
determine how and when the mismatch happened between dietary
intake and dosed insulin. Second, participants are not representative
of all youth with type 1 diabetes and had an HbA1c range of 8%–13%
and duration of diabetes N1 year. Third, two days of 24-h recalls may
not capture usual dietary intake, and reporting bias may occur. Fourth,
the small sample size precludes assessment of potential interactions
among nutrients and effect modifications by baseline glycemic status,
diabetes duration, and pubertal status. Fifth, we did not consider the
severity of hypoglycemia which is related to duration of low blood
glucose b70 mg/dL and the lowest glucose concentration within a
hypoglycemic episode. Sixth, residual confounding may be likely. For
example, moderate or vigorous exercise, a known factor related to
hypoglycemia in children with type 1 diabetes,36 was not included in
the final models according to our pre-specified covariates inclusion
criterion requiring P ≤ 0.2, although further accounting for it did not
make a difference (data not shown). More precise and objective
measurement of physical activity would be important in future
studies. Finally, the definition of nocturnal hypoglycemia is arbitrary,
although 11 PM–7AM threshold is commonly used in the
literature.18,23
In conclusion, we found that different nutrients had different
association with the occurrence of non-severe hypoglycemia in
free-living adolescents with type 1 diabetes. Also, dietary intake was
differentially associatedwith risk of non-severe hypoglycemia between
daytime and nighttime. To reduce hypoglycemia risk, current insulin
dosing recommendations mainly based on carbohydrate counting may
need to bemodified. Calculating insulin dosemay consider several other
nutrition factors including soluble fiber, total protein, MUFA, PUFA, and
theGI. Further research is required tobetter understand the relationship
among dietary intake, insulin dosing, and risk of hypoglycemia,
especially in type 1 adolescents. Such studies need to collect insulin
dose and time of injection for each meal during the study period.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jdiacomp.2017.04.017.
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